Sichuan University study links ZP gene variants to female infertility
Researchers at Sichuan University found 14 variants in three zona pellucida genes tied to poor assisted reproduction outcomes in 12 women with primary infertility. The findings suggest early genetic testing could help explain repeated IVF failure and guide treatment choices.
Why it matters: - Zona pellucida gene defects may help explain some cases of unexplained female infertility and repeated assisted reproductive technology failure. - The findings could influence how fertility clinics evaluate patients who have poor egg retrieval, abnormal eggs, or repeated IVF failure. - The study points to genetic testing as a way to identify when standard fertility treatment is unlikely to work and when alternatives may be needed.
What happened: - A Sichuan University team led by Professor Qian-hong Ma conducted a retrospective genetic analysis of women with infertility and zona pellucida abnormalities. - The study examined 12 women with primary infertility and persistent poor ART outcomes. - Researchers analyzed blood DNA using next-generation sequencing and Sanger sequencing. - The paper was made available online on Feb. 11, 2025, and published April 15, 2025, in BJOG: An International Journal of Obstetrics & Gynaecology.
The details: - The team identified 14 genetic variants across three zona pellucida genes. - The variants included three in ZP1, five in ZP2 and four in ZP3. - Eight of the 14 variants were novel and had not been reported before. - ZP3 helps sperm recognize and bind to the egg. - ZP2 supports continued sperm interaction. - ZP1 stabilizes the zona pellucida structure. - In some patients, immature or degenerated eggs were linked to ZP1 variants. - Some patients showed genuine empty follicle syndrome, where ultrasound suggests normal follicle growth but no eggs are retrieved. - Certain ZP1 variants were predicted to disrupt formation of a functional zona pellucida. - ZP2 variants were linked to structural abnormalities, including eggs lacking a zona pellucida, enlarged spaces around the egg and abnormal sperm binding patterns. - ZP3 variants were associated with abnormal zona pellucida appearance and poor egg retrieval. - Some eggs had a rigid or “waxy” outer layer. - In some patients, multiple follicles developed but very few viable eggs were obtained.
Between the lines: - The study adds to evidence that infertility can have a measurable genetic basis even when ovarian follicles appear normal. - The clinical pattern suggests different zona pellucida genes may affect different steps of fertilization and early embryo development. - The researchers said the small sample size and retrospective design limit how broadly the results can be applied.
What’s next: - The researchers called for further studies to confirm the genetic effects and test how well screening could fit into fertility care. - For patients with zona pellucida abnormalities, the team suggested intracytoplasmic sperm injection, which injects a single sperm directly into the egg. - For severe genetic defects affecting egg development, donor eggs may be needed. - Prof. Ma said genetic screening could help identify underlying biological causes of infertility and support more personalized treatment strategies. - More information is available in the original paper.
The bottom line: - Zona pellucida gene variants appear to be linked to difficult-to-treat infertility and may help explain why some IVF cycles fail despite normal-looking follicles.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
University Research Times
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.